Skip to main content
Clinical Trials/NCT05811871
NCT05811871
Not yet recruiting
Not Applicable

Examining Variables Affecting Patient Participation in Clinical Trials for Tinnitus

Power Life Sciences Inc.0 sites500 target enrollmentApril 2024
ConditionsTinnitus

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Tinnitus
Sponsor
Power Life Sciences Inc.
Enrollment
500
Primary Endpoint
Number of tinnitus patients who decide to enroll in a clinical study
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

Clinical trials can sometimes favor certain demographic groups. Additionally, there is limited research that delves into the factors that influence participation in clinical trials, both positive and negative.

The goal is to identify the obstacles and challenges that prevent participation in tinnitus clinical studies, as well as the reasons for withdrawal or discontinuation.

The insights gained from this study will ultimately benefit those with tinnitus who may be invited to participate in clinical research in the years to come.

Registry
clinicaltrials.gov
Start Date
April 2024
End Date
April 2026
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Diagnosed with tinnitus
  • Willing to comply with all study related procedures and assessments
  • Ability to understand and the willingness to sign a written informed consent document.

Exclusion Criteria

  • No documented diagnosis of tinnitus
  • Any other health problems that would prohibit safe participation in the study
  • Pregnant or planning to become pregnant while enrolled in the study

Outcomes

Primary Outcomes

Number of tinnitus patients who decide to enroll in a clinical study

Time Frame: 3 months

Rate of tinnitus patients who remain in a clinical study to completion

Time Frame: 12 months

Similar Trials